Exagen inc. to announce first quarter 2025 financial results on may 5, 2025

Carlsbad, calif., april 21, 2025 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing, will release financial results for the quarter ended march 31, 2025, before the market opens on monday, may 5, 2025. john aballi, exagen's president and chief executive officer, and jeff black, chief financial officer, will host a conference call to review the company's results at 8:30 a.m. et (5:30 a.m. pt).
XGN Ratings Summary
XGN Quant Ranking